DermaGen AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private, Subsidiary
- Established
- 2004-05-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.dermagen.se
A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: DPK-060 1% ointmentDrug: Placebo for DPK-060 ointment
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- DermaGen AB
- Target Recruit Count
- 41
- Registration Number
- NCT01522391
- Locations
- 🇸🇪
Quintiles Hermelinen AB, Luleå, Sweden
A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis
Phase 2
Completed
- Conditions
- Acute Otitis Externa
- Interventions
- Drug: Placebo for DPK-060 ear drops
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- DermaGen AB
- Target Recruit Count
- 69
- Registration Number
- NCT01447017
- Locations
- 🇸🇪
Hagakliniken, Gothenburg, Sweden
🇸🇪Curakliniken, Malmö, Sweden
🇸🇪Me3+ Clinical Trials, Gothenburg, Sweden
© Copyright 2025. All Rights Reserved by MedPath